TrialClinical lymphoma, myeloma & leukemia2015

Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial.

Yasuhiro Oki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.